Graphite Bio Graphite Bio
  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Academic Founders
    • A Name with Purpose
  • Our Science
    • Overview
    • Pipeline
    • Publications
    • Expanded Access Policy
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Resources
  • News & Media
    • Top News
    • Media Inquiries
  • Contact
    • Overview
  • Careers
    • Join Us
  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Academic Founders
    • A Name with Purpose
  • Our Science
    • Overview
    • Pipeline
    • Publications
    • Expanded Access Policy
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Resources
  • News & Media
    • Top News
    • Media Inquiries
  • Contact
    • Overview
  • Careers
    • Join Us

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events & Presentations
    • Events
    • Presentations
  • Corporate Governance
    • Committee Composition
    • Executive Team
    • Board of Directors
    • Documents & Charters
  • Financials & Filings
  • Stock Information
  • Resources
    • Contacts
    • Investor FAQs
    • Analyst Coverage
    • Email Alerts
Jan 27, 2022 8:00am EST

Graphite Bio Announces Participation in Upcoming Investor Conferences

Dec 11, 2021 9:00am EST

Graphite Bio Presents Overview of Phase 1/2 CEDAR Trial Evaluating Investigational Gene Editing Therapy GPH101 in Sickle Cell Disease at 63rd ASH Annual Meeting and Exposition

Dec 07, 2021 8:00am EST

Graphite Bio to Host Key Opinion Leader Webinar on Gene Correction for Sickle Cell Disease

Nov 17, 2021 8:00am EST

Graphite Bio Enrolls First Patient in Phase 1/2 Clinical Trial of GPH101 for Sickle Cell Disease

Nov 10, 2021 4:05pm EST

Graphite Bio Reports Recent Business Progress and Third Quarter 2021 Financial Results

Nov 04, 2021 9:13am EDT

Graphite Bio Announces Presentation on Phase 1/2 CEDAR Trial of GPH101 in Sickle Cell Disease at Upcoming 63rd ASH Annual Meeting and Exposition

Oct 21, 2021 8:00am EDT

Graphite Bio Announces Participation in Upcoming Jefferies Gene Therapy/Editing Summit

Oct 12, 2021 1:00pm EDT

Graphite Bio Presents Preclinical Data Supporting GPH101 in Sickle Cell Disease at 49th Annual Sickle Cell Disease Association of America National Convention

Oct 05, 2021 8:00am EDT

Graphite Bio Announces Upcoming Presentation at 49th Annual Sickle Cell Disease Association of America National Convention

Aug 30, 2021 8:00am EDT

Graphite Bio Announces Participation in Upcoming September Investor Conferences

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • About Us
  • Overview
  • Leadership
  • Board of Directors
  • Scientific Advisory Board
  • Academic Founders
  • A Name with Purpose
  • Our Science
  • Overview
  • Pipeline
  • Publications
  • Expanded Access Policy
  • Investors
  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Resources
  • News & Media
  • Top News
  • Media Inquiries
  • Contact
  • General Inquiries
  • Careers
  • Overview

Graphite Bio, Inc.

201 Haskins Way, Suite 210
South San Francisco, CA 94080
United States of America

Graphite Bio
  • Terms of Use
  • Privacy Policy
  • Social Media
  • Cal Compliance

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Graphite Bio, its subsidiaries or affiliates. No use of any Graphite Bio trademark, trade name, or trade dress in this site may be made without the prior written authorization of Graphite Bio, except to identify the product or services of the company.

©Copyright 2021 Graphite Bio, Inc. All rights reserved.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie Duration Description
cookielawinfo-checbox-analytics 11 months This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional 11 months The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others 11 months This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary 11 months This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance 11 months This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy 11 months The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT